Inside CURE Epilepsy: Funding Science, Saving Lives

A cure mindset changes everything. That’s the animating force behind our conversation with Beth Dean, CEO of CURE Epilepsy, as we unpack how a parent-founded nonprofit reframed a field long focused on treatments and built a pipeline that backs bold science, supports families, and accelerates breakthroughs. Beth shares why her path from industry to advocacy sharpened a simple truth: the right funding at the right moment can be the difference between stalled labs and lifesaving progress.

Where do we go next? Two forces stand out. AI promises to mine electronic health records and registries for patterns that can replace trial-and-error prescribing with smarter, faster seizure control. Genetics continues to expand the map of implicated genes, opening doors for CRISPR, AAV, and antisense therapies that address root causes. Across it all, the mission stays human: connecting families desperate for answers to leading centers, backing innovators willing to take risks, and turning scattered insights into a path to seizure freedom.

If you care about faster cures, smarter care, and keeping scientists at the bench, this conversation offers a clear roadmap and practical ways to help. Subscribe, share this episode with someone who needs hope, and leave a review to help more people find it.